Nanocarriers applied to the treatment of breast cancer
Autor(a) principal: | |
---|---|
Data de Publicação: | 2021 |
Outros Autores: | , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Research, Society and Development |
Texto Completo: | https://rsdjournal.org/index.php/rsd/article/view/18966 |
Resumo: | Objective: Evaluate the implications of using nanocarriers in the treatment of breast cancer. Methods: Literature review based in guidelines contained in Preferred Reporting Items for Systematic reviews and Meta-analyses (PRISMA), using these databases: PubMed and Biblioteca Virtual em Saúde, using the key words: “nanoparticles” AND “treatment” AND “breast cancer”. Nineteen articles, written in English, that met the inclusion criteria, were selected. Results: Given the findings on the selected studies, it was perceived a low toxicity on healthy cells and the capacity to direct nanoparticles to the tumor site. Conclusion: The present study allowed the comprehension of the efficacy of de drugs carried on the different nanoparticles, intending to reduce the tumoral cells and minimize the toxicity, with specific liberation of drugs on tumor site. |
id |
UNIFEI_55aa391445bffb5e3c97bb08ea87a101 |
---|---|
oai_identifier_str |
oai:ojs.pkp.sfu.ca:article/18966 |
network_acronym_str |
UNIFEI |
network_name_str |
Research, Society and Development |
repository_id_str |
|
spelling |
Nanocarriers applied to the treatment of breast cancer Nanoportadores aplicados al tratamiento del cáncer de mamaNanocarreadores aplicados ao tratamento do câncer de mamaNanoparticleTreatmentBreast neoplasms. NanopartículasTratamientoNeoplasias de la mama.TratamentoNanopartículasNeoplasias de mama.Objective: Evaluate the implications of using nanocarriers in the treatment of breast cancer. Methods: Literature review based in guidelines contained in Preferred Reporting Items for Systematic reviews and Meta-analyses (PRISMA), using these databases: PubMed and Biblioteca Virtual em Saúde, using the key words: “nanoparticles” AND “treatment” AND “breast cancer”. Nineteen articles, written in English, that met the inclusion criteria, were selected. Results: Given the findings on the selected studies, it was perceived a low toxicity on healthy cells and the capacity to direct nanoparticles to the tumor site. Conclusion: The present study allowed the comprehension of the efficacy of de drugs carried on the different nanoparticles, intending to reduce the tumoral cells and minimize the toxicity, with specific liberation of drugs on tumor site.Objetivo: Evaluar las implicaciones del uso de nanoportadores en el tratamiento del cáncer de mama. Metodología: Revisión de la literatura basada en las pautas contenidas en los elementos de informe preferidos para revisiones sistemáticas y metaanálisis (PRISMA), utilizando las bases de datos: PubMed y Virtual Health Library con los términos de búsqueda: “nanopartículas” Y “tratamiento” Y “cáncer de mama”. Se seleccionaron diecinueve artículos, escritos en inglés, que cumplieron con los criterios de inclusión. Resultados: Con base en los hallazgos de los estudios seleccionados, se observó que los nanoportadores tienen baja toxicidad para las células sanas y que las nanopartículas pueden dirigirse a la ubicación específica del tumor. Conclusíon: este estudio permitió comprender la efectividad de los fármacos utilizados en diferentes tipos de nanoportadores para la reducción de células tumorales con minimización de la toxicidad y liberación del fármaco en la región específica del tumor.Objetivo: Avaliar as implicações da utilização dos nanocarreadores no tratamento do câncer de mama. Métodos: Revisão da literatura com base nas diretrizes contidas no Preferred Reporting Items for Systematic reviews and Meta-analyses (PRISMA), utilizando as bases de dados: PubMed e Biblioteca Virtual em Saúde com os termos de busca: “nanopartículas” E “tratamento” E “câncer de mama”. Foram selecionados 19 artigos, escritos em inglês, que preencheram os critérios de inclusão. Resultados: Diante dos achados nos estudos selecionados, percebeu-se que os nanocarreadores apresentam baixa toxicidade a células saudáveis e as nanopartículas podem ser direcionadas para o local específico do tumor. Conclusão: este estudo permitiu compreender a eficácia das drogas utilizadas nos diferentes tipos de nanocarreadores para a redução das células tumorais com minimização da toxicidade e liberação do medicamento na região específica do tumor.Research, Society and Development2021-08-14info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/1896610.33448/rsd-v10i10.18966Research, Society and Development; Vol. 10 No. 10; e392101018966Research, Society and Development; Vol. 10 Núm. 10; e392101018966Research, Society and Development; v. 10 n. 10; e3921010189662525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIporhttps://rsdjournal.org/index.php/rsd/article/view/18966/16951Copyright (c) 2021 Marina Galdino da Rocha Pitta; Rhuann Pontes dos Santos Silva; Guilherme Victor Santos Alves; Isabella Carla Barbosa Lima Angelo; Joana Martins de Souza; João Ricardo Caldas Pinheiro Pessôa; Jordy Silva de Carvalho; Maria Keyllane Vasconcelos de Miranda; Manuela Barbosa Rodrigues de Souzahttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessPitta, Marina Galdino da Rocha Silva, Rhuann Pontes dos Santos Alves, Guilherme Victor Santos Angelo, Isabella Carla Barbosa Lima Souza, Joana Martins de Pessôa, João Ricardo Caldas Pinheiro Carvalho, Jordy Silva de Miranda, Maria Keyllane Vasconcelos de Souza, Manuela Barbosa Rodrigues de 2021-10-02T21:49:16Zoai:ojs.pkp.sfu.ca:article/18966Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-01-17T09:38:58.279642Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false |
dc.title.none.fl_str_mv |
Nanocarriers applied to the treatment of breast cancer Nanoportadores aplicados al tratamiento del cáncer de mama Nanocarreadores aplicados ao tratamento do câncer de mama |
title |
Nanocarriers applied to the treatment of breast cancer |
spellingShingle |
Nanocarriers applied to the treatment of breast cancer Pitta, Marina Galdino da Rocha Nanoparticle Treatment Breast neoplasms. Nanopartículas Tratamiento Neoplasias de la mama. Tratamento Nanopartículas Neoplasias de mama. |
title_short |
Nanocarriers applied to the treatment of breast cancer |
title_full |
Nanocarriers applied to the treatment of breast cancer |
title_fullStr |
Nanocarriers applied to the treatment of breast cancer |
title_full_unstemmed |
Nanocarriers applied to the treatment of breast cancer |
title_sort |
Nanocarriers applied to the treatment of breast cancer |
author |
Pitta, Marina Galdino da Rocha |
author_facet |
Pitta, Marina Galdino da Rocha Silva, Rhuann Pontes dos Santos Alves, Guilherme Victor Santos Angelo, Isabella Carla Barbosa Lima Souza, Joana Martins de Pessôa, João Ricardo Caldas Pinheiro Carvalho, Jordy Silva de Miranda, Maria Keyllane Vasconcelos de Souza, Manuela Barbosa Rodrigues de |
author_role |
author |
author2 |
Silva, Rhuann Pontes dos Santos Alves, Guilherme Victor Santos Angelo, Isabella Carla Barbosa Lima Souza, Joana Martins de Pessôa, João Ricardo Caldas Pinheiro Carvalho, Jordy Silva de Miranda, Maria Keyllane Vasconcelos de Souza, Manuela Barbosa Rodrigues de |
author2_role |
author author author author author author author author |
dc.contributor.author.fl_str_mv |
Pitta, Marina Galdino da Rocha Silva, Rhuann Pontes dos Santos Alves, Guilherme Victor Santos Angelo, Isabella Carla Barbosa Lima Souza, Joana Martins de Pessôa, João Ricardo Caldas Pinheiro Carvalho, Jordy Silva de Miranda, Maria Keyllane Vasconcelos de Souza, Manuela Barbosa Rodrigues de |
dc.subject.por.fl_str_mv |
Nanoparticle Treatment Breast neoplasms. Nanopartículas Tratamiento Neoplasias de la mama. Tratamento Nanopartículas Neoplasias de mama. |
topic |
Nanoparticle Treatment Breast neoplasms. Nanopartículas Tratamiento Neoplasias de la mama. Tratamento Nanopartículas Neoplasias de mama. |
description |
Objective: Evaluate the implications of using nanocarriers in the treatment of breast cancer. Methods: Literature review based in guidelines contained in Preferred Reporting Items for Systematic reviews and Meta-analyses (PRISMA), using these databases: PubMed and Biblioteca Virtual em Saúde, using the key words: “nanoparticles” AND “treatment” AND “breast cancer”. Nineteen articles, written in English, that met the inclusion criteria, were selected. Results: Given the findings on the selected studies, it was perceived a low toxicity on healthy cells and the capacity to direct nanoparticles to the tumor site. Conclusion: The present study allowed the comprehension of the efficacy of de drugs carried on the different nanoparticles, intending to reduce the tumoral cells and minimize the toxicity, with specific liberation of drugs on tumor site. |
publishDate |
2021 |
dc.date.none.fl_str_mv |
2021-08-14 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/18966 10.33448/rsd-v10i10.18966 |
url |
https://rsdjournal.org/index.php/rsd/article/view/18966 |
identifier_str_mv |
10.33448/rsd-v10i10.18966 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/18966/16951 |
dc.rights.driver.fl_str_mv |
https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Research, Society and Development |
publisher.none.fl_str_mv |
Research, Society and Development |
dc.source.none.fl_str_mv |
Research, Society and Development; Vol. 10 No. 10; e392101018966 Research, Society and Development; Vol. 10 Núm. 10; e392101018966 Research, Society and Development; v. 10 n. 10; e392101018966 2525-3409 reponame:Research, Society and Development instname:Universidade Federal de Itajubá (UNIFEI) instacron:UNIFEI |
instname_str |
Universidade Federal de Itajubá (UNIFEI) |
instacron_str |
UNIFEI |
institution |
UNIFEI |
reponame_str |
Research, Society and Development |
collection |
Research, Society and Development |
repository.name.fl_str_mv |
Research, Society and Development - Universidade Federal de Itajubá (UNIFEI) |
repository.mail.fl_str_mv |
rsd.articles@gmail.com |
_version_ |
1797052818695127040 |